An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer

European Journal of Surgical Oncology

Volumn 34, Issue 11, 2008, Pages 1208-1216

  Liu, T S ^a   Wang, Y ^a   Chen, S Y ^a   Sun, Y H ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Adjuvant chemotherapy; Gastric cancer; Meta analysis; Randomized controlled clinical trial

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN; SEMUSTINE; TEGAFUR; VINBLASTINE;

ADJUVANT THERAPY; ALOPECIA; ANEMIA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RELAPSE; CANCER SURGERY; CLINICAL TRIAL; DIARRHEA; DISEASE FREE SURVIVAL; DRUG TOLERABILITY; HUMAN; INFECTION; LEUKOPENIA; LIVER INJURY; META ANALYSIS; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; GASTRECTOMY; HUMANS; POSTOPERATIVE CARE; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 44949240000     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.02.002     Document Type: Review

References (49)

1. Katherine D.C., and Alfred I.N. Epidemiology of gastric cancer. World J Gastroenterol 12 3 (2006) 354-363
2. Parkin D., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J Clin 49 1 (1999) 33-64
3. Hermans J., Bonenkamp J.J., Boon M., et al. Adjuvant therapy after curative resection for gastric cancer: a meta-analysis of randomized trials. J Clin Oncol 11 8 (1993) 1441-1447
4. Earle C., and Maroun J. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35 7 (1999) 1059-1064
5. Mari E., Floriani I., Tinazzi A., et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. Ann Oncol 11 7 (2000) 837-843
6. Ochiai T., Sato H., Hayashi R., Asano T., Sato H., and Yamamura Y. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. Three- to six-year follow-up of a randomized clinical trial. Cancer Immunol Immunother 14 3 (1983) 167-171
7. Jakesz R., Dittrich C., Funovics J., et al. The effect of adjuvant chemotherapy in gastric carcinoma is dependent on tumor histology: 5-year results of a prospective randomized trial. Recent Results Cancer Res 110 1988 (1988) 44-51
8. Allum W.H., Hallissey M.T., and Kelly K.A. Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial. Lancet 1 Mar (1989) 571-574
9. Hallissey M.T., Dunn J.A., Ward L.C., and Allum W.H. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 343 8909 (1994) 1309-1312
10. Panzini I., Gianni L., Fattori P.P., et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 88 1 (2002) 21-27
11. Higgins G.A., Amadeo J.H., Smith D.E., Humphrey E.W., and Keehn R.J. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report. Cancer 52 6 (1983) 1105-1112
12. Neri B., Leonardis V., Romano S., et al. Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multi-centre randomised study. Br J Cancer 73 4 (1996) 549-552
13. Alderson P, Green S, Higgins JPT, editors. Cochrane reviewers' handbook 4.2.3, section 9.2 [updated May 2005]. Available at http://www.cochrane.dk/cochrane//handbook/hbook.htm.
14. Lau J., Ioannidis J.P., and Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 127 (1997) 820-826
15. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
16. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
17. Alcobendas F., Milla A., Estape J., Curto J., and Pera C. Mitomycin-C as an adjuvant in resected gastric cancer. Ann Surg 198 1 (1983) 13-17
18. Sakuramoto S., Sasakoa M., Yamaguchi T., et al. Adjuvant chemotherapy using S-1 for curatively resected gastric cancer: the nationwide clinical trial. N Engl J Med 357 18 (2007) 1810-1820
19. Bouché O., Ychou M., Burtin P., et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol 16 9 (2006) 1488-1497
20. Estape J., Grau J.J., Lcobendas F., et al. Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up. Ann Surg 213 3 (1991) 219-221
21. Blake J.R., Hardcastle J.D., and Wilson R.G. Gastric cancer: a controlled trial of adjuvant chemotherapy following gastrectomy. Clin Oncol 7 1 (1981) 13-27
22. Petrioli R., Sabatino M., Roviello F., et al. Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer. Hepato-Gastroenterol 52 65 (2005) 1626-1630
23. Maehara Y., Emi Y., Sugimachi K., et al. Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection. J Surg Oncol 45 3 (1990) 169-172
24. Bonfanti G., Gennari L., Bozzette F., et al. Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group. Br J Surg 75 (1988) 1100-1104
25. Bajetta E., Aitini E., Bozzetti F., et al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Ann Oncol 13 2 (2002) 299-307
26. Chou F.F., Sheen-Chen S.M., Liu P.P., and Chen F.C. Adjuvant chemotherapy for resectable gastric cancer: a preliminary report. J Surg Oncol 57 4 (1994) 239-242
27. Cirera L., Balil A., Batiste-Alentorn E., et al. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. J Clin Oncol 17 12 (1999) 3810-3815
28. Coombes R.C., Schein P.S., Chilvers C.E.D., et al. A randomised trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. J Clin Oncol 8 8 (1990) 1362-1369
29. Engstrom P.F., Lavin P.T., Douglass H.O., and Brunner K.W. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern cooperative oncology group study (EST 3275). Cancer 55 9 (1985) 1868-1873
30. Grau J.J., Estape J., Alcobendas F., et al. Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients. Eur J Cancer 29A 3 (1993) 340-342
31. Huguier M., Destroyes J.P., Baschet C., Henand F., and Bernard P.F. Gastric carcinoma treated by chemotherapy after resection. Am J Surg 139 2 (1980) 197-199
32. Krook J.E., O'Connell M.J., Wieand H.S., et al. A prospective randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer 67 10 (1991) 2454-2458
33. Lise M., Nitti D., Marchet A., et al. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. J Clin Oncol 13 11 (1995) 2757-2763
34. Nakajima T., Nashimoto A., Kitamura M., et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group. Lancet 354 24 (1999) 273-277
35. Tsavaris N., Tentas K., Kosmidis P., et al. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer. Chemotherapy 42 3 (1996) 220-226
36. Douglass H.O., Stablein D.M., Bruckner H.M., et al. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group. Cancer 49 (1982) 1116-1122
37. Macdonald J.S., Fleming T.R., Peterson R.F., et al. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: a Southwest Oncology Group study. Ann Surg Oncol 2 6 (1995) 488-494
38. Nashimoto A., Nakajima T., Furukawa H., et al. Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 21 12 (2003) 2282-2287
39. Neri B., Cini G., Andreoli G., et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. Br J Cancer 84 7 (2001) 878-880
40. Chipponi J., Huguier M., Pezet D., et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg 187 3 (2004) 440-445
41. Bresciani C., Waitzberg D.L., Matsuda M., Gama-Rodrigues J., Strassmann V., and Pinotti H.W. Long term (five-year) survival following radical surgical treatment plus adjuvant chemotherapy (FAM) in advanced gastric cancer: a controlled study. Rev Hosp Clin Fac Med Sao Paulo 55 4 (2001) 129-136
42. Uslu A., Karaca C., Nart A., et al. Adjuvant chemotherapy in a unique population of patients with gastric cancer undergoing surgery. Hepato-Gastroenterol 51 58 (2004) 1245-1248
43. Nakajima T., Fukami A., Ohashi I., and Kajitani T. Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C. Int J Clin Pharmacol Biopharm 16 5 (1978) 209-216
44. Schlag P., Schreml W., Gaus W., et al. Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: three-year results. Recent Results Cancer Res 80 1982 (1982) 277-283
45. Nakajima T., Takahashi T., Takagi K., Kuno K., and Kajitani T. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol 2 12 (1984) 1366-1371
46. Hartgrink H.H., Van de Volde C.J.H., Bonenkamp J.J., et al. Extended lymph-node dissection for gastric cancer: who may benefit? Final results of randomized Dutch Gastric Cancer Group trial. J Clin Oncol 22 11 (2004) 2069-2077
47. Kim J.P. Immunochemosurgery as a new approach to reasonable treatment of advanced cancer. Ann Acad Med Singapore. 17 (1988) 48-54
48. Yamamura Y., Nishimura M., Sakamoto J., et al. A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer. Gan To Tagaku Ryoho 13 (1986) 2134-2140
49. Schiessel R., Funovies J., Schick B., et al. Adjuvant intraperitoneal cisplatin in patients with operated gastric carcinoma: results of a randomized trial. Acta Med Aust 16 (1989) 68-69